---
title: "Honz: The company's product Levocetirizine Hydrochloride Granules has been selected for the centralized bulk procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei-Jiangxi region"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273668472.md"
description: "Honz announced that its product Levocetirizine Hydrochloride Granules has been selected for the centralized procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei region, with a specification of 2.5mg, indicated for conditions such as urticaria and allergic rhinitis. The selection results will be officially implemented on March 1, 2026, with an annual signing during the procurement cycle. The selection will help expand market sales and increase market share, positively impacting the company's long-term development; however, the contract has not yet been signed, and there is uncertainty regarding the progress and its impact on future performance"
datetime: "2026-01-26T08:01:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273668472.md)
  - [en](https://longbridge.com/en/news/273668472.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273668472.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273668472.md) | [繁體中文](https://longbridge.com/zh-HK/news/273668472.md)


# Honz: The company's product Levocetirizine Hydrochloride Granules has been selected for the centralized bulk procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei-Jiangxi region

Honz announced that its product, Levocetirizine Hydrochloride Granules, has been selected for the centralized bulk procurement of chemical drugs led by Hebei Province in the Beijing-Tianjin-Hebei region. The selected product specification is 2.5mg, and the indications include urticaria, allergic rhinitis, eczema, dermatitis, and pruritus. The results of this selection will officially take effect on March 1, 2026, with an annual signing during the procurement cycle. After selection, it will help expand the market sales of the selected product, increase market share, and have a positive impact on the company's long-term development. However, the relevant procurement contract has not yet been signed, and there is uncertainty regarding the actual progress and its impact on the company's future performance

### Related Stocks

- [Honz (300086.CN)](https://longbridge.com/en/quote/300086.CN.md)

## Related News & Research

- [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/en/news/281570860.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md)
- [11:33 ETFitness, Health and Wellness Experts Team Up to 'Get Fit for No Kid Hungry' with New On-Demand Initiative](https://longbridge.com/en/news/281213207.md)
- [Miraval Resorts & Spas and Humin Set New Standard for the Future of Measurable Wellness with Groundbreaking New Study | H Stock News](https://longbridge.com/en/news/281216315.md)
- [Trafigura rejects Bolivia's claim that its fuel contracts were suspended](https://longbridge.com/en/news/281507689.md)